Smart forecasting of artifacts in contrast-enhanced breast MRI before contrast agent administration.
Andrzej LiebertBadhan K DasLorenz A KapsnerJessica EberleDominika SkwierawskaLukas FolleHannes SchreiterFrederik B LaunSabine OhlmeyerMichael UderEvelyn WenkelSebastian BickelhauptPublished in: European radiology (2023)
• Potentially significant artifacts can be observed in a relevant proportion of breast MRI subtraction sequences after gadolinium-based contrast agent administration (GBCA). • Forecasting the occurrence of such artifacts in subtraction maximum intensity projections before GBCA administration for individual patients was feasible at 89% specificity, which allowed correctly predicting one in three future artifacts. • Further research is necessary to investigate the clinical value of such smart personalized imaging approaches.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- diffusion weighted
- magnetic resonance
- computed tomography
- image quality
- dual energy
- diffusion weighted imaging
- end stage renal disease
- ejection fraction
- newly diagnosed
- cone beam
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- current status
- patient reported